CLSI C56 A : 1ED 2012
Current
The latest, up-to-date edition.
HEMOLYSIS, ICTERUS, AND LIPEMIA/TURBIDITY INDICES AS INDICATORS OF INTERFERENCE IN CLINICAL LABORATORY ANALYSIS
Hardcopy , PDF
English
13-07-2012
Abstract
Committee Membership
Foreword
1 Scope
2 Introduction
3 Standard Precautions
4 Terminology
5 Scientific Basis of Hemolysis, Icterus, and
Lipemia/Turbidity Indices
6 Use of Hemolysis, Icterus, and
Lipemia/Turbidity Indices
7 Determination of Hemolysis, Icterus, and
Lipemia/Turbidity Indices
8 Estimation of Hemolysis, Icterus,
Lipemia/Turbidity Interference Effects
9 Establishing Hemolysis, Icterus, and
Lipemia/Turbidity Alert Indices and Gray Zones
10 Reporting Hemolysis, Icterus, and
Lipemia/Turbidity Interference Claims by Manufacturers
in Product Labeling
11 Potential Process Outcomes of Interferent
Measurements/Estimates
12 Suggested Annotation Terminology for Result
Reporting
13 Verification and Quality Control of Hemolysis,
Icterus, and Lipemia/Turbidity Indices and Alert
Indices in the Clinical Laboratory
References
Appendix A - Path of Workflow for Hemolysis, Icterus,
and Lipemia/Turbidity Measurements in the
Clinical Laboratory
Appendix B - Worked Example of Establishing
Hemolysis, Icterus, and Lipemia/Turbidity
Indices
The Quality Management System Approach
Related CLSI Reference Materials
Important note : All end users must be registered with an Account prior to user licenses being assigned.Access your standards online with a subscription
Features
-
Simple online access to standards, technical information and regulations.
-
Critical updates of standards and customisable alerts and notifications.
-
Multi-user online standards collection: secure, flexible and cost effective.